Education
About Us
Working with TipRanks
Follow Us
bioMerieux (FR:BIM)
:BIM
Total Valuation
bioMerieux has a market cap or net worth of €13.44B. The enterprise value is €12.36B.
Market Cap€13.44B
Enterprise Value€12.36B
Share Statistics
bioMerieux has 118,361,220 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding118,361,220
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
bioMerieux’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 9.73%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.73%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee303.00K
Profits Per Employee32.36K
Employee Count13,135
Asset Turnover0.69
Inventory Turnover1.70
Valuation Ratios
The current PE Ratio of bioMerieux is 28.20. bioMerieux’s PEG ratio is 1.34.
PE Ratio28.20
PS Ratio3.11
PB Ratio2.90
Price to Fair Value2.90
Price to FCF37.91
Price to Operating Cash Flow18.27
PEG Ratio1.34
Income Statement
In the last 12 months, bioMerieux had revenue of 3.98B and earned 432.20M in profits. Earnings per share was 3.67.
Revenue3.98B
Gross Profit2.22B
Operating Income614.70M
Pretax Income579.40M
Net Income432.20M
EBITDA909.50M
Earnings Per Share (EPS)3.67
Cash Flow
In the last 12 months, operating cash flow was 494.60M and capital expenditures -338.20M, giving a free cash flow of 156.40M billion.
Operating Cash Flow494.60M
Free Cash Flow156.40M
Free Cash Flow per Share1.32
Dividends & Yields
bioMerieux pays an annual dividend of €0.899, resulting in a dividend yield of 0.75%
Dividend Per Share€0.899
Dividend Yield0.75%
Payout Ratio23.23%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change13.92%
50-Day Moving Average114.90
200-Day Moving Average106.25
Relative Strength Index (RSI)47.86
Average Volume (3m)148.13K
Important Dates
bioMerieux upcoming earnings date is Sep 4, 2025, TBA Not Confirmed.
Last Earnings DateMar 7, 2025
Next Earnings DateSep 4, 2025
Ex-Dividend DateJun 09, 2025
Financial Position
bioMerieux as a current ratio of 2.20, with Debt / Equity ratio of 0.00%
Current Ratio2.20
Quick Ratio1.29
Debt to Market Cap0.00
Net Debt to EBITDA-0.49
Interest Coverage Ratio125.45
Taxes
In the past 12 months, bioMerieux has paid 154.30M in taxes.
Income Tax154.30M
Effective Tax Rate0.27
Enterprise Valuation
bioMerieux EV to EBITDA ratio is 12.91, with an EV/FCF ratio of 36.51.
EV to Sales2.95
EV to EBITDA12.91
EV to Free Cash Flow36.51
EV to Operating Cash Flow17.59
Balance Sheet
bioMerieux has €272.20M in cash and marketable securities with €547.00M in debt, giving a net cash position of €286.30M billion.
Cash & Marketable Securities€272.20M
Total Debt€547.00M
Net Cash€286.30M
Net Cash Per Share€2.42
Tangible Book Value Per Share€25.38
Margins
Gross margin is 52.97%, with operating margin of 15.45%, and net profit margin of 10.86%.
Gross Margin52.97%
Operating Margin15.45%
Pretax Margin14.56%
Net Profit Margin10.86%
EBITDA Margin22.85%
EBIT Margin14.68%
Analyst Forecast
The average price target for bioMerieux is €133.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€133.17
Price Target Upside17.12% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast8.31%
EPS Growth Forecast21.00%